🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Radiolabeled monoclonal antibodies can locate tumor cells and de...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
1999-11
Trial ID
NCT00005592
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab and yttrium Y 90 ibritum...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2003-02-10
Trial ID
NCT00058422
This phase I trial is studying how well monoclonal antibody therapy with pe...
Status
Completed
Location
Johns Hopkins University
Start Date
2001-04
Trial ID
NCT00017381
Phase I/II trial to study the effectiveness of combining radiolabeled monoc...
Status
Terminated
Location
Mayo Clinic
Start Date
2001-04
Trial ID
NCT00012298
Primary Objective: * Overall Response Rate (ORR). Secondary Objectives: ...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2006-04
Trial ID
NCT00493454
Treatments Being Tested
This study is a regulatory post-marketing surveillance of Zevalin (ibritumo...
Status
Completed
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT01479387
Treatments Being Tested
Monoclonal antibodies such as rituximab and yttrium Y 90 ibritumomab tiuxet...
Status
Terminated
Location
Northwestern University
Start Date
2003-10-28
Trial ID
NCT00089284
Treatments Being Tested
Phase I/II trial to study the effectiveness of combining yttrium Y 90 ibrit...
Status
Completed
Location
AIDS - Associated Malignancies Clinical Trials Consortium
Start Date
2003-07
Trial ID
NCT00064246
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab and yttrium Y 90 ibritu...
Status
Completed
Location
Memorial Sloan - Kettering Cancer Center
Start Date
2004-12
Trial ID
NCT00082836
Treatments Being Tested
This phase II trial studies the side effects and how well high-dose yttrium...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2011-11-16
Trial ID
NCT01434472